Australia - English - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - carbimazole, quantity: 5 mg - tablet, multilayer - excipient ingredients: lactose monohydrate; sucrose; acacia; maize starch; purified talc; magnesium stearate; gelatin; iron oxide red - therapy of hyperthyroidism. definitive therapy: induction of a permanent remission, in either primary or secondary thyrotoxicosis. preparation for thyroidectomy. before and after radioactive iodine treatment.

Australia - English - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - trifluoperazine hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - trifluoperazine hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - biperiden hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - flumetasone pivalate, quantity: 0.2 mg/ml; clioquinol, quantity: 10 mg/ml - ear drops - excipient ingredients: macrogol 300 - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. new indications were approved as specified in the letter of 29 june 1992 from dr alex proudfoot. indicated for the treatment of eczema of the external auditory meatus in which secondary infection with micro-organisms sensitive to clioquinol has occurred. otitis externa. otomycosis.

Australia - English - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - hydroxocobalamin acetate, quantity: 1.044 mg - injection, solution - excipient ingredients: water for injections; glacial acetic acid; sodium chloride - prophylaxis and treatment of pernicious (addisonian) anaemia and other macrocytic anaemias associated with vitamin b12 deficiency. treatment of optic neuropathies such as tobacco amblyopia and leber's optic atrophy.

Australia - English - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - cyclizine lactate, quantity: 50 mg/ml - injection - excipient ingredients: lactic acid; water for injections - valoid is indicated for the prevention of nausea and vomiting in the post operative period

Australia - English - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - erythromycin ethyl succinate -

Australia - English - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - hydroxocobalamin acetate, quantity: 1.044 mg - injection, solution - excipient ingredients: water for injections; glacial acetic acid; sodium chloride - prophylaxis and treatment of pernicious (addisonian) anaemia and other macrocytic anaemias associated with vitamin b12 deficiency. treatment of optic neuropathies such as tobacco amblyopia and leber's optic atrophy.

Australia - English - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - trifluoperazine hydrochloride -